JP2023527747A5 - - Google Patents

Info

Publication number
JP2023527747A5
JP2023527747A5 JP2022570302A JP2022570302A JP2023527747A5 JP 2023527747 A5 JP2023527747 A5 JP 2023527747A5 JP 2022570302 A JP2022570302 A JP 2022570302A JP 2022570302 A JP2022570302 A JP 2022570302A JP 2023527747 A5 JP2023527747 A5 JP 2023527747A5
Authority
JP
Japan
Prior art keywords
lipid
approximately
pharmaceutically acceptable
item
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022570302A
Other languages
English (en)
Japanese (ja)
Other versions
JP7863051B2 (ja
JP2023527747A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/032676 external-priority patent/WO2021236479A2/en
Publication of JP2023527747A publication Critical patent/JP2023527747A/ja
Publication of JP2023527747A5 publication Critical patent/JP2023527747A5/ja
Application granted granted Critical
Publication of JP7863051B2 publication Critical patent/JP7863051B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022570302A 2020-05-18 2021-05-17 新規脂質及びそれらのナノ粒子組成物 Active JP7863051B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063026479P 2020-05-18 2020-05-18
US63/026,479 2020-05-18
PCT/US2021/032676 WO2021236479A2 (en) 2020-05-18 2021-05-17 Novel lipids and nanoparticle compositions thereof

Publications (3)

Publication Number Publication Date
JP2023527747A JP2023527747A (ja) 2023-06-30
JP2023527747A5 true JP2023527747A5 (cg-RX-API-DMAC7.html) 2024-05-24
JP7863051B2 JP7863051B2 (ja) 2026-05-20

Family

ID=78707483

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022570302A Active JP7863051B2 (ja) 2020-05-18 2021-05-17 新規脂質及びそれらのナノ粒子組成物

Country Status (9)

Country Link
US (1) US20230181764A1 (cg-RX-API-DMAC7.html)
EP (1) EP4153144A4 (cg-RX-API-DMAC7.html)
JP (1) JP7863051B2 (cg-RX-API-DMAC7.html)
CN (1) CN115968280A (cg-RX-API-DMAC7.html)
AU (1) AU2021274481A1 (cg-RX-API-DMAC7.html)
CA (1) CA3175957A1 (cg-RX-API-DMAC7.html)
IL (1) IL298241A (cg-RX-API-DMAC7.html)
MX (1) MX2022014484A (cg-RX-API-DMAC7.html)
WO (1) WO2021236479A2 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3864163T3 (da) 2018-10-09 2024-05-06 Univ British Columbia Sammensætninger og systemer omfattende transfektionskompetente vesikler fri for organiske opløsningsmidler og rengøringsmidler og fremgangsmåder forbundet dermed
AU2021307952A1 (en) * 2020-07-17 2023-03-02 Generation Bio Co. Methods for encapsulating polynucleotides into reduced sizes of Lipid nanoparticles and novel formulation thereof
CN114716355B (zh) * 2022-04-02 2023-09-05 华南理工大学 一种脂质化合物、包含其的组合物及应用
CN121532216A (zh) * 2023-04-18 2026-02-13 赛仁生物技术公司 腺相关病毒载体组合物和使用方法
EP4719352A1 (en) 2023-05-31 2026-04-08 Capstan Therapeutics, Inc. Lipid nanoparticle formulations and compositions
CN120330264A (zh) * 2024-01-19 2025-07-18 晟迪生物医药(苏州)有限公司 基于空白脂质纳米颗粒的转染试剂、其制备方法和应用
WO2026003582A2 (en) 2024-06-27 2026-01-02 Axelyf ehf. Lipids and lipid nanoparticles

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0610479D0 (en) * 2006-05-26 2006-07-05 Ge Healthcare Bio Sciences Ab A method for generating metal chelating affinity ligands
WO2013073480A1 (ja) 2011-11-18 2013-05-23 日油株式会社 細胞内動態を改善したカチオン性脂質
JP6640750B2 (ja) * 2015-01-30 2020-02-05 日油株式会社 カチオン性脂質
US11395798B2 (en) * 2015-10-08 2022-07-26 Nof Corporation O/W type emulsion
WO2018237369A2 (en) * 2017-06-23 2018-12-27 Vical Incorporated Lipid nanoparticle (lnp)-mediated delivery of a crispr-expressing plasmid dna for treating chronic hepatitis b virus infection
CA3075168A1 (en) 2017-09-08 2019-03-14 Generation Bio Co. Modified closed-ended dna (cedna)
CA3094057C (en) * 2018-03-27 2025-04-08 Nof Corporation CATIONIC LIPID WITH IMPROVED INTRACELLULAR DYNAMICS
CN114929205B (zh) * 2019-09-06 2024-09-03 世代生物公司 包括末端封闭式dna和可切割脂质的脂质纳米颗粒组合物及其使用方法
WO2021060440A1 (ja) * 2019-09-26 2021-04-01 日油株式会社 脂質ナノ粒子の凍結乾燥組成物
AU2020385378A1 (en) * 2019-11-22 2022-04-07 Generation Bio Co. Ionizable lipids and nanoparticle compositions thereof
CA3162019A1 (en) 2019-12-20 2021-06-24 Gemma NAVARRO Lipid nanoparticles for delivery of nucleic acids

Similar Documents

Publication Publication Date Title
JP2023502576A5 (cg-RX-API-DMAC7.html)
JP2023518985A5 (cg-RX-API-DMAC7.html)
JP2022546597A5 (cg-RX-API-DMAC7.html)
JP2023534043A5 (cg-RX-API-DMAC7.html)
JP2024517644A5 (cg-RX-API-DMAC7.html)
US12252470B2 (en) Lipids and nanoparticle compositions thereof
JP2024522692A5 (cg-RX-API-DMAC7.html)
CN116437964A (zh) 用于将多核苷酸封装成减小尺寸的脂质纳米颗粒以及其新型调配物的方法
US20240293574A1 (en) Cationic lipids and compositions thereof
JP2024520756A5 (cg-RX-API-DMAC7.html)
KR20230172570A (ko) 양이온성 지질 및 이의 조성물
US20230181764A1 (en) Novel lipids and nanoparticle compositions thereof
WO2024119103A1 (en) Lipid nanoparticles comprising nucleic acids and lipid-anchored polymers
RU2023129760A (ru) Катионные липиды и их композиции
RU2023135629A (ru) Катионные липиды и их композиции